mHealth to Enhance & Sustain Drug Use Reduction of the QUIT BI in Primary Care

NARecruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Drug Use
Interventions
BEHAVIORAL

Usual Care

Usual Care participants will receive their standard medical care as usual and all study assessments. Providers will not receive information about their drug use. To reduce Hawthorne effect biases and to mask the study's purpose, RAs will provide the Usual Care arm patients with a cancer screening booklet and have them view a cancer screening Video Doctor. Participants will receive re-contact calls (5 min) to provide attentional control for the Usual Care arm, motivate continued trial participation by reminding next research assessment and study incentives, update contact information, and address participation barriers, but do not provide intervention. At study end, Usual Care will receive the QUIT video doctor and drug use reduction booklet materials including overdose prevention materials and a list of clinic/community resources to help them reduce substance use.

BEHAVIORAL

QUIT Intervention (doctor brief advice, video doctor, health coaching sessions at 2- and 6-weeks)

"QUIT's core components include:~1. patient screening with the WHO Alcohol Smoking and Substance Involvement Screening Test (ASSIST, score 4-26);~2. face-to-face brief clinician advice on reducing drug use (2-3 minutes);~3. video doctor reinforcing the clinician message;~4. drug use reduction brochure;~5. 2- and 6-week telephone health coaching sessions to enhance self-efficacy in reducing drug use, via motivational interviewing and cognitive behavior therapy (CBT) techniques (20-30 minutes)."

BEHAVIORAL

QUIT-Mobile (QUIT Intervention plus weekly mobile-web app or text message weekly self-monitoring, automated feedback over 12 months)

"The QUIT-Mobile intervention includes QUIT's core components and adds:~1. SMS/IVR/mobile-app self-monitoring survey prompts twice-weekly during the QUIT coaching through 6 weeks, and then weekly self-monitoring and automated feedback via SMS/IVR/app through 12-months.~2. Web-based dashboards will be used by coaches for monitoring of patients' self-monitoring data to enhance 2- and 6-week coaching sessions and for monitoring during the post-coaching self-management and monitoring period from 7-weeks to 12-months and intervening accordingly. The mobile platform will provide the same intervention functions (self-monitoring surveys and feedback messages) and robust data transfer protocols across three mobile technology platforms."

Trial Locations (5)

90011

RECRUITING

South Central Family Health Clinic, Los Angeles

90013

RECRUITING

Wesley Health Centers, Los Angeles

90038

RECRUITING

Saban Community Clinic, Los Angeles

90044

RECRUITING

UMMA Community Clinic, Los Angeles

90806

RECRUITING

The Children's Clinic (TCC) Family Health, Long Beach

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

University of Arkansas

OTHER

collaborator

Medical University of South Carolina

OTHER

lead

University of California, Los Angeles

OTHER